At Sniff ’n’ Waggle, we prioritise evidence-based minerals that contribute meaningfully to canine health. Zinc Chelate (Amino Acid Complex) is one such ingredient—an easily absorbed form of zinc that supports skin integrity, coat quality, and normal tissue repair.
What is Zinc Chelate (Amino Acid Complex)?
Zinc chelate is zinc bound to amino acids to aid absorption. Zinc is an essential trace mineral that contributes to healthy skin, coat, and immune function. Chelation improves bioavailability and stability in complex formulations.
How Zinc Supports Skin, Coat & Tissue Health
Zinc acts as a cofactor for enzymes involved in skin integrity, keratin formation, wound repair, and antioxidant defences. Chelated forms are efficiently absorbed through the intestinal wall, helping to maintain optimal zinc status.
Natural Compounds for Overall Wellbeing
By supporting enzyme systems throughout the body, zinc contributes to normal growth, tissue renewal, and immune resilience.
Frequently Asked Questions
Why use a chelated form of zinc?
Chelation can improve intestinal uptake versus some inorganic salts, supporting more reliable delivery in complex formulas.
Is Zinc Chelate safe for dogs?
Yes, when used within authorised limits in complete feeds and supplements.
What does zinc actually do for the coat?
Zinc supports normal skin turnover and hair-shaft protein structure, helping maintain a healthy skin barrier and coat condition.
The Bottom Line: Zinc Chelate for Dogs’ Skin & Coat
Zinc chelate is a well‑tolerated and bioavailable way to support skin, coat, and tissue health. Sniff ’n’ Waggle includes chelated zinc to deliver consistent results within multi‑nutrient blends. Consult your vet before starting supplements, particularly if your dog has underlying conditions.
References
- EFSA Journal 2012;10(3):2621: The additive is concluded to be a safe and efficacious source of zinc for all animal species (pets/dogs are included), provided the maximum authorized EU zinc levels are respected (200 mg Zn/kg complete feed for dogs and cats).
https://www.efsa.europa.eu/en/efsajournal/pub/2621 - EFSA Journal 2013;11(10):3369: This publication officially updated the characterization of the substance but explicitly stated that the conclusions on the safety and efficacy reached in the earlier 2012 opinion (2621) remained unchanged for all species.
https://www.efsa.europa.eu/en/efsajournal/pub/3369